PRTG - Top Stocks in the News LXRX, SYTA, DBVT, WIMI, MLGO, and PRTG

2025-03-28 10:07:36 ET

DENVER, Colo., Mar 28, 2025 ( 247marketnews.com )- Lexicon Pharmaceuticals (NASDAQ: LXRX) just inked a blockbuster deal with Novo Nordisk A/S, handing over the keys to LX9851, a first-in-class oral non-incretin obesity drug, in an exclusive worldwide license worth up to $1 billion. Announced today, the pact nets Lexicon $75 million upfront and near-term milestone cash, with the potential for a $1 billion in development, regulatory, and sales payouts—plus tiered royalties on every sale.

LX9851, Lexicon’s brainchild, is a potent oral inhibitor of Acyl-CoA Synthetase 5 (ACSL5)—a fat-regulating powerhouse that tweaks energy balance and fires up the ileal brake to curb appetite and slow digestion. Preclinical data from Obesity Week 2024 lit up the charts: paired with semaglutide, LX9851 slashed weight, appetite, and fat mass beyond semaglutide’s solo punch. Post-semaglutide, it tamed weight regain and eased liver fat—a double whammy for the $100 billion obesity market.

Siyata Mobile (NASDAQ:SYTA) is gearing up to release its Q4 and full-year 2024 financial report on March 31, 2025, but don’t expect the usual earnings call chatter. This time, Siyata’s playing a different game.

With the upcoming blockbuster Core Gaming merger, the combined companies’ leaders will present at the AI & Technology Virtual Investor Conference on April 3, Core’s CEO Aitan Zacharin will unpack the strategy fueling this seismic shift VirtualInvestorConferences.com at 10:30 AM ET.

Siyata’s not just a Push-to-Talk (PoC) handset maker anymore; its $185 million merger with Core Gaming is rewriting the playbook. Core, a Miami-based mobile gaming titan, boasts $80 million in 2024 revenue, 40 million monthly active users (MAUs), and 600 million downloads across 2,000+ games in 140 countries. ValueScope pegged Core’s November valuation at $185.9 million and Zacharin’s April 3 presentation promises to dive into its AI-powered growth, think apps that hook players and rake in cash, eyeing a $126 billion mobile gaming market.

DBV Technologies (NASDAQ:DBVT) just closed a blockbuster financing deal worth up to $306.9 million (€284.5 million) to turbocharge its Viaskin Peanut Patch. The haul includes $125.5 million (€116.3 million) upfront and up to $181.4 million (€168.2 million) more if warrants fully cash out, fueling the patch’s sprint through a Biologics License Application (BLA) to the FDA and a potential U.S. launch for kids aged 4-7, pending approval.

WiMi Hologram Cloud (NASDAQ:WIMI) just dropped a bombshell: it boosted its stake in MicroAlgo (NASDAQ:MLGO) to a hefty 67.65%. Plus, it’s locking in its shares for 10-years.

This move sees WiMi, a Beijing-based augmented reality (AR) innovator, tightening its grip on MicroAlgo, a tech outfit dabbling in algorithm optimization and quantum research. WiMi now holds 40,000 Class A common shares, 1.8 million restricted Class A shares, and a whopping 44.9 million restricted Class B shares.

The lock-up’s the real kicker. A decade-long commitment screams confidence, signaling WiMi sees MicroAlgo as a long-haul winner.

WiMi’s not new to MicroAlgo, as it held 63.32% and $23 million in convertible notes. The lock-up keeps MLGO’s float tight at 2 million shares, potentially fueling a squeeze, with 17% short interest still lurking.

Portage Biotech (NASDAQ:PRTG) unveiled a breakthrough at the 2025 European Lung Cancer Congress (ELCC) in Paris. New preclinical data for PORT-7 (TT-4), a selective Adenosine A2B receptor inhibitor, showcased jaw-dropping results against mesothelioma, a notoriously tough cancer. Presented by Dr. Luciano Mutti of Gruppo Italiano Mesotelioma e Oncologia Ambientale, the findings revealed single-agent tumor suppression and a stunning >90% tumor growth halt when paired with an anti-PD1 antibody in a murine model. Tumor analysis lit up with CD3 and CD45 immune cells storming in, hinting at a revved-up immune attack.

Please click here to view ValueScope’s Core Gaming valuation report or additional 247marketnews.com Siyata disclosure at https://247marketnews.com/syta-siyata/

The post Top Stocks in the News LXRX, SYTA, DBVT, WIMI, MLGO, and PRTG appeared first on 24/7 MarketNews .

For further details see: